Mechanistically, MTCH2 deficiency promotes the proteasome‐dependent ubiquitination of E2F4 and attenuates transcriptional inhibition of transferrin receptor (TFRC) by E2F4, ultimately facilitating TFRC‐mediated ferroptosis in CRC cells. This evidence concerns the gene E2F4 and colorectal carcinoma.